logo

Akari Therapeutics Plc (AKTX)



Trade AKTX now with
  Date
  Headline
10/6/2020 8:38:59 AM Akari Announces Further Progress In COVID-19 Pneumonia Program With Nomacopan In US, Brazil
9/29/2020 11:10:19 AM Akari Therapeutics To Present Its Phase III Plans At IPPF Patient Education Conference
9/1/2020 8:39:01 AM Akari Therapeutics Q2 Net Loss $8.3 Mln Vs Net Loss $4.1 Mln Last Year
8/31/2020 7:09:21 AM Akari Therapeutics Announces Intl Clinical Development Program Of Nomacopan For COVID-19 Pneumonia
7/1/2020 11:15:42 AM Akari Therapeutics Appoints Torsten Hombeck As CFO
7/1/2020 9:17:38 AM Akari Therapeutics Appoints Torsten Hombeck CFO
9/13/2019 8:07:31 AM Akari Therapeutics: FDA Grants Orphan Drug Designation For Nomacopan For Bullous Pemphigoid
8/30/2019 7:04:45 AM Akari Therapeutics Says FDA Granted Orphan Drug Designation For Nomacopan
8/29/2019 8:13:49 AM Akari Therapeutics Q2 Net Loss $4.1 Mln Vs Loss Of $8.0 Mln Last Year
4/23/2019 8:35:10 AM Akari Therapeutics Announces Positive Initial Phase II Clinical Data In Orphan Skin Disease Bullous Pemphigoid
11/15/2018 6:51:26 AM Akari Therapeutics Q3 Net Loss $3.6 Mln Vs Net Loss $10.4 Mln Last Year
9/27/2018 7:10:02 AM Akari Therapeutics Q2 Net Loss $8.0 Mln Vs Loss Of $0.3 Mln Last Year
9/27/2018 7:07:27 AM Akari Therapeutics Enters Securities Purchase Agreement For Up To $20 Mln With Aspire Capital Fund, LLC